Table 2.
Relationship between miR-124 expression and their clinicopathological parameters in 67 esophageal cancer patients
| Clinicolpathological parameters | Number of cases | Expression of miR-124 | P -value |
|---|---|---|---|
| Age (years) | |||
| <60 | 38 | 1.301 ± 0.8616 | 0.8220 |
| ≥60 | 29 | 1.344 ± 0.6687 | |
| Gender: | |||
| Male | 52 | 1.267 ± 0.7489 | 0.3017 |
| Female | 15 | 1.504 ± 0.8765 | |
| Tumor size (cm): | |||
| ≤4 | 45 | 1.344 ± 0.8002 | 0.7154 |
| >4 | 22 | 1.270 ± 0.7485 | |
| Degree of differentiation: | |||
| Well and moderately | 27 | 1.590 ± 0.8159 | 0.0182* |
| Poorly | 40 | 1.137 ± 0.7052 | |
| Local invasion: | |||
| T1 + T2 | 24 | 1.604 ± 0.6710 | 0.0245* |
| T3 + T4 | 43 | 1.161 ± 0.7965 | |
| TNM stage: | |||
| StageI + II | 42 | 1.434 ± 0.8117 | 0.1192 |
| Stage III + IV | 25 | 1.127 ± 0.6930 | |
| Metastasis: | |||
| No | 41 | 1.362 ± 0.7076 | 0.5831 |
| Yes | 26 | 1.253 ± 0.8900 |
P-value represents the probability from a Student’s t-test for miR-124 expression between variable subgroups. *P < 0.05 was considered to have a significant difference.